ArticleFrontiers in oncology2022

Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer.

Carlos Contreras-Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.